Literature DB >> 30897357

Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS.

Casey Cook1, Leonard Petrucelli2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disorder that orchestrates an attack on the motor nervous system that is unrelenting. Recent discoveries into the pathogenic consequences of repeat expansions in C9ORF72, which are the most common genetic cause of ALS, combined with the identification of new genetic mutations are providing novel insight into the underlying mechanism(s) that cause ALS. In particular, the myriad of functions linked to ALS-associated genes have collectively implicated four main pathways in disease pathogenesis, including RNA metabolism and translational biology; protein quality control; cytoskeletal integrity and trafficking; and mitochondrial function and transport. Through the identification of common disease mechanisms on which multiple ALS genes converge, key targets for potential therapeutic intervention are highlighted.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30897357     DOI: 10.1016/j.neuron.2019.02.032

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  42 in total

1.  Presynaptic Homeostasis Opposes Disease Progression in Mouse Models of ALS-Like Degeneration: Evidence for Homeostatic Neuroprotection.

Authors:  Brian O Orr; Anna G Hauswirth; Barbara Celona; Richard D Fetter; Giulia Zunino; Evgeny Z Kvon; Yiwen Zhu; Len A Pennacchio; Brian L Black; Graeme W Davis
Journal:  Neuron       Date:  2020-05-06       Impact factor: 17.173

Review 2.  Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins.

Authors:  Michael Fernandopulle; GuoZhen Wang; Jonathon Nixon-Abell; Seema Qamar; Varun Balaji; Ryuta Morihara; Peter H St George-Hyslop
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 3.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 4.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.

Authors:  Claudia Fallini; Bilal Khalil; Courtney L Smith; Wilfried Rossoll
Journal:  Neurobiol Dis       Date:  2020-03-14       Impact factor: 5.996

Review 6.  New Roles for Canonical Transcription Factors in Repeat Expansion Diseases.

Authors:  Lindsey D Goodman; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-12-11       Impact factor: 11.639

Review 7.  Mitochondrial Miro GTPases coordinate mitochondrial and peroxisomal dynamics.

Authors:  Konrad E Zinsmaier
Journal:  Small GTPases       Date:  2020-11-12

Review 8.  Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.

Authors:  Alexandra C M Van Harten; Hemali Phatnani; Serge Przedborski
Journal:  Trends Neurosci       Date:  2021-05-15       Impact factor: 13.837

9.  G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD.

Authors:  Alyssa N Coyne; Benjamin L Zaepfel; Lindsey Hayes; Boris Fitchman; Yuval Salzberg; En-Ching Luo; Kelly Bowen; Hannah Trost; Stefan Aigner; Frank Rigo; Gene W Yeo; Amnon Harel; Clive N Svendsen; Dhruv Sareen; Jeffrey D Rothstein
Journal:  Neuron       Date:  2020-07-15       Impact factor: 17.173

10.  Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss.

Authors:  Steven Rodriguez; Asli Sahin; Benjamin R Schrank; Hawra Al-Lawati; Isabel Costantino; Eric Benz; Darian Fard; Alefiya D Albers; Luxiang Cao; Alexis C Gomez; Kyle Evans; Elena Ratti; Merit Cudkowicz; Matthew P Frosch; Michael Talkowski; Peter K Sorger; Bradley T Hyman; Mark W Albers
Journal:  Sci Transl Med       Date:  2021-07-07       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.